A Combination of Testosterone and White Blood Cell Count as a Predictive Factor of Overall Survival in Localized Prostate Cancer

ConclusionsA high WBC and lymphocyte count combined with normal testosterone levels increases the overall mortality of patients treated with radiotherapy for localized prostate cancer within the first 6 –7 years post-treatment. Validation in larger cohorts is necessary.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research